[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 699
Citations 0
November 2017

Prior Authorizations for Diagnostic Skin Biopsies: Does Anyone Benefit?

Author Affiliations
  • 1Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland
JAMA Dermatol. 2017;153(11):1091-1092. doi:10.1001/jamadermatol.2017.3516

In dermatology, prior authorizations (PAs) have become a common administrative tool that payers use to manage the utilization of biologics and other expensive therapies.1 PAs require physicians to obtain pretreatment approval from a patient’s insurer for the reimbursement of a specific drug or service. PAs are meant to control costs by preventing the inappropriate use of medical resources.